In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
AION Labs, In Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations
Mobile Health Times
AION Labs, Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS), seeks global research talent for new startup focused on: “Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations”.
Global Call for Scientists and Inventors to Form New Startup
Labiotech.eu
AION Labs and German independent research institute BioMed X, announced today (June 29) the launch of the fourth global call for application to identify biomedical scientists and inventors to form a new startup in Israel. This fourth startup will focus on the development of an AI platform that optimizes the patient population for phase 3 clinical trial oncology studies.